Cuban and Iranian regimes strengthen ties: Havana to experience Sovereign 02 vaccine with Iranians

The Cuban and Iranian regimes strengthen their ties and decide to test one of the controversial vaccines developed by Havana with the Iranian population. It is that this Monday the third phase of the trial clinical Cuban Sovereign Vaccine 02 – locally called Pasteur – which will involve 24,000 volunteers from seven provinces in the north, center and south of this Middle Eastern country.

The start of the The trials in Iran began with an official ceremony at the University of Medical Sciences in the city of Isfahan in central Iran, in the presence of the Minister of Health, Saíd Namaki and with the injection of the vaccine to four volunteers.Iranian local news agency reported ISNA.

The director of the Center for the management of infectious diseases of the Ministry of Health, Mohamad Mehdi Guya and the director of Pasteur Institute of Iran, Alireza Biglarí, these are the first two injected. “Today, our country has produced one of the best, most effective and dynamic coronavirus vaccines in the world at the Institut Pasteur“, He said Namakí in a speech made on site.

Namakí added that “the generals in the field of vaccine production have done their job, there is no brake and Iran is the region’s brightest country in COVID-19 vaccine production. “

Controversy and disinformation

In mid-April, a disinformation campaign led by Havana had underlined that the World Health Organization (WHO) had assigned the category “excellence” to Sovereign 02. However, it was a fake news promoted by the regime. Not even WHO nor its subsidiary in America, the OPS, gave the “category of excellenceCuban vaccine against COVID-19, as posts that have gone viral on social networks claim.

The entity clarified that “WHO does not evaluate vaccines“And recalled that the Sovereign 02”has not yet completed its clinical trial phases“. “WHO evaluates them once they have completed their 3 phases ”and it is at this point that“ the producer submits them to WHO for their prequalification or their inclusion in the list of emergency uses.The agency added.

Likewise, he sent a link that shows the list of vaccines and the state in which they are evaluating the WHO and in which the vaccine candidates Sovereign 01, Sovereign 02 Yes Soberana More -the most advanced of Cuba– they meet in “discussion“In the first stage known as EOI (expression of interest). During this process, the producer must provide WHO with the necessary documents to initiate their assessment, which focuses on their development process and timeline.

Agreement

According to the agreement signed last January between the Institute Finlay vaccine (IFV) of Havana and the Pastor Institute, the third and final test phase Sovereign 02 It will also be held in the Persian country, and then the technology to produce the drug will be transferred locally.

This vaccine candidate has started the final phase of clinical trials in Havana on March 8 with 44,010 volunteers, and at the end of the month, testing was expanded with a parallel intervention study on another 150,000 people.

To carry out the tests in Iran, some 100,000 doses of the vaccine to be tested in volunteers aged 18 to 80.

The Ayatollah official detailed today on state television that It is expected that two million doses of this serum will be produced “monthly” and by early June it will be supplied for general vaccination in the country, although it still does not have international approval. fame.

Eight universities of medical sciences from Mazandaran, Babol, Isfahan, Yazd, Kerman, Hormozgan, Zanyan and Hamedan are participating in the trials.

In “Yazd and Zanyan”, a booster dose will be given, in addition to the two doses of the vaccine, as Biglarí had previously explained to the local ISNA news agency.

According to Biglarí “Booster dose may be effective in boosting immunity in people who have previously been infected with covid-19”.

Iran is currently going through the fourth wave of the pandemic with daily highs of infections. On the other hand, it is locally develop several vaccine preparations and yesterday began the third phase of clinical trials of its most advanced local vaccine called COVID-19 COVIRAN Barekat.

A total of 165,655 people received both doses of a vaccine in Iran, and some 618,362 people received only the first injection.

The total death toll in the country is around 70,000 people and the number of people infected is around 2.4 million people.

KEEP READING: